{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:26:25Z","timestamp":1791573985579,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012729","name":"Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012729","name":"Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012729","name":"Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012729","name":"Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012729","name":"Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["T32 EY024236"],"award-info":[{"award-number":["T32 EY024236"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objectives<\/jats:title>\n                    <jats:p>Data on the prevalence of optic neuritis (ON) is limited with reported rates between 5.5 and 115.3 per 100,000. The US data is even more limited with the largest study performed in a single county, finding a prevalence of 115.3. This study aims to fill the gap in US data on ON.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This (2016\u20132023) cross-sectional study included patients with ICD-10 codes of retrobulbar neuritis, other ON, unspecified ON, and excluded those with optic papillitis, nutritional optic neuropathy, toxic optic neuropathy. Data was collected through a series of queries in a large platform (TriNetX, LLC) containing EHR data from over 113 million patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2023, the prevalence of ON was 51.6 per 100,000 people in the overall population. Females had a 1.31 (95% CI, 1.27\u20131.36) increased odds of disease compared to males. Investigating racial\u00a0and ethnic breakdown, the highest prevalence was found in the Black population (57.8\/100,000) (OR 1.06 (1.01\u20131.10)), followed by the White (54.7\/100,000) (REF) and then Hispanic or Latino populations (45.8\/100,000) (OR 0.84 (0.79\u20130.89)) in 2023. Stratified by age, those ages 45\u201354 had the highest prevalence (71.3\/100,000). The prevalence of ON increased 1.08 (1.05\u20131.10) times from 2016\u20132023, with the greatest increase seen in the Hispanic population. Significant increases in prevalence were also seen in the 0\u201314, 15\u201324, and 25\u201334 age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Racial,\u00a0ethnic and sex disparities are apparent in the distribution of ON, with Black individuals and females affected most often, and an increasing prevalence seen in the Hispanic population. Younger subpopulations also demonstrated significant increases, warranting additional investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-025-03683-8","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:44:17Z","timestamp":1740566657000},"page":"1608-1614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of pediatric and adult optic neuritis in the United States from 2016 to 2023"],"prefix":"10.1038","volume":"39","author":[{"given":"Nadia J.","family":"Abbass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline K.","family":"Shaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-8162","authenticated-orcid":false,"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"3683_CR1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0196-0644(84)80072-4","volume":"13","author":"J Javerbaum","year":"1984","unstructured":"Javerbaum J, Mitchell JA, Dawson R. Optic neuritis. Ann Emerg Med. 1984;13:1061\u20134.","journal-title":"Ann Emerg Med"},{"key":"3683_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0002-9394(14)74662-8","volume":"92","author":"TA Cox","year":"1981","unstructured":"Cox TA, Stanley Thompson H, Corbett JJ. Relative Afferent Pupillary Defects in Optic Neuritis. Am J Ophthalmol. 1981;92:685\u201390.","journal-title":"Am J Ophthalmol"},{"key":"3683_CR3","first-page":"309","volume":"29","author":"K Loncarek","year":"2005","unstructured":"Loncarek K, Brajac I, Petricek I, Stalekar H, Cerovski B, Pokupe R. Epidemiology of monosymptomatic optic neuritis in Rijeka County, Croatia: meteorological aspects. Coll Antropol. 2005;29:309\u201313.","journal-title":"Coll Antropol"},{"key":"3683_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1001\/archopht.1972.01000020137004","volume":"87","author":"AK Percy","year":"1972","unstructured":"Percy AK, Nobrega FT, Kurland LT. Optic Neuritis and Multiple Sclerosis: An Epidemiologic Study. Arch Ophthalmol. 1972;87:135\u20139.","journal-title":"Arch Ophthalmol"},{"key":"3683_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajem.2007.01.021","volume":"25","author":"CA Germann","year":"2007","unstructured":"Germann CA, Baumann MR, Hamzavi S. Ophthalmic diagnoses in the ED: optic neuritis. Am J Emerg Med. 2007;25:834\u20137.","journal-title":"Am J Emerg Med"},{"key":"3683_CR6","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","volume":"360","author":"S Hickman","year":"2002","unstructured":"Hickman S, Dalton C, Miller D, Plant G. Management of acute optic neuritis. Lancet. 2002;360:1953\u201362.","journal-title":"Lancet"},{"key":"3683_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","volume":"261","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2014;261:17\u201326.","journal-title":"J Neurol"},{"key":"3683_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485\u20139.","journal-title":"Neurology"},{"key":"3683_CR9","doi-asserted-by":"publisher","first-page":"177.e1","DOI":"10.1016\/j.ajem.2018.10.001","volume":"37","author":"NP Yee","year":"2019","unstructured":"Yee NP, Kashani S, Mailhot T, Omer T. More than meets the eye: Point-of-care ultrasound diagnosis of acute optic neuritis in the emergency department. Am J Emerg Med. 2019;37:177.e1\u2013177.e4.","journal-title":"Am J Emerg Med"},{"key":"3683_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/archneur.1962.04210040005001","volume":"7","author":"M Alter","year":"1962","unstructured":"Alter M, Halpern L, Kurland LT, Bornstein B, Leibowitz U, Silberstein J. Multiple Sclerosis in Israel: Prevalence Among Immigrants and Native Inhabitants. Arch Neurol. 1962;7:253\u201363.","journal-title":"Arch Neurol"},{"key":"3683_CR11","first-page":"1017","volume":"41","author":"SR Cole","year":"2000","unstructured":"Cole SR, Beck RW, Moke PS, Gal RL, Long DT. Optic Neuritis Study Group. The National Eye Institute Visual Function Questionnaire: Experience of the ONTT. Invest Ophthalmol Vis Sci. 2000;41:1017\u201321.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3683_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/09286580902737516","volume":"16","author":"SA Lim","year":"2009","unstructured":"Lim SA, Wong WL, Fu E, Goh KY, Seah A, Tan C, et al. The Incidence of Neuro-Ophthalmic Diseases in Singapore: A Prospective Study in Public Hospitals. Ophthalmic Epidemiol. 2009;16:65\u201373.","journal-title":"Ophthalmic Epidemiol"},{"key":"3683_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.23.6.631","volume":"23","author":"M Alter","year":"1973","unstructured":"Alter M, Good J, Okihiro M. Optic neuritis in Orientals and Caucasians. Neurology. 1973;23:631\u2013631.","journal-title":"Neurology"},{"key":"3683_CR14","first-page":"117","volume":"48","author":"M Gr\u00f8nning","year":"1989","unstructured":"Gr\u00f8nning M, Mellgren SI, Schive K. Optic neuritis in the two northernmost counties of Norway. A study of incidence and the prospect of later development of multiple sclerosis. Arctic Med Res. 1989;48:117\u201321.","journal-title":"Arctic Med Res"},{"key":"3683_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0022-510X(98)00141-5","volume":"159","author":"YP Jin","year":"1998","unstructured":"Jin YP, de Pedro-Cuesta J, S\u00f6derstr\u00f6m M, Stawiarz L, Link H. Incidence of optic neuritis in Stockholm, Sweden 1990\u20131995: I. Age, sex, birth and ethnic-group related patterns. J Neurol Sci. 1998;159:107\u201314.","journal-title":"J Neurol Sci"},{"key":"3683_CR16","first-page":"343","volume":"28","author":"L Boji\u0107","year":"2004","unstructured":"Boji\u0107 L, Ivanisevi\u0107 M, Sini\u0107i\u0107 A, Lesin M, Rogosi\u0107 V, Mandi\u0107 Z, et al. The incidence of optic neuritis in Split-Dalmatia county, Croatia. Coll Antropol. 2004;28:343\u20137.","journal-title":"Coll Antropol"},{"key":"3683_CR17","first-page":"93","volume":"99","author":"M Wakakura","year":"1995","unstructured":"Wakakura M, Ishikawa S, Oono S, Tabuchi A, Kani K, Tazawa Y, et al. [Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)]. Nippon Ganka Gakkai Zasshi. 1995;99:93\u20137.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"3683_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-0404.1983.tb04846.x","volume":"68","author":"E Kinnunen","year":"1983","unstructured":"Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand. 1983;68:371\u20137.","journal-title":"Acta Neurol Scand"},{"key":"3683_CR19","first-page":"10","volume":"11","author":"S Congia","year":"1989","unstructured":"Congia S, Vacca MA, Tronci S. Epidemiologic and clinical features of optic neuritis in the 20th and 21st sanitary districts of the Sardinia (Italy). Acta Neurol. 1989;11:10\u20134.","journal-title":"Acta Neurol"},{"key":"3683_CR20","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","volume":"77","author":"T Braithwaite","year":"2020","unstructured":"Braithwaite T, Subramanian A, Petzold A, Galloway J, Adderley NJ, Mollan SP, et al. Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease. JAMA Neurol. 2020;77:1514\u201323.","journal-title":"JAMA Neurol"},{"key":"3683_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez M, Siva A, Cross SA, O\u2019Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995;45:244\u201350.","journal-title":"Neurology"},{"key":"3683_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","volume":"220","author":"MB Hassan","year":"2020","unstructured":"Hassan MB, Stern C, Flanagan EP, Pittock SJ, Kunchok A, Foster RC, et al. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Am J Ophthalmol. 2020;220:110\u20134.","journal-title":"Am J Ophthalmol"},{"key":"3683_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00415-014-7266-2","volume":"261","author":"EH Mart\u00ednez-Lapiscina","year":"2014","unstructured":"Mart\u00ednez-Lapiscina EH, Fraga-Pumar E, Pastor X, G\u00f3mez M, Conesa A, Lozano-Rub\u00ed R, et al. Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008\u20132012. J Neurol. 2014;261:759\u201367.","journal-title":"J Neurol"},{"key":"3683_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000112858","volume":"29","author":"LC Woung","year":"2008","unstructured":"Woung LC, Lin CH, Tsai CY, Tsai MT, Jou JR, Chou P. Optic Neuritis among National Health Insurance Enrollees in Taiwan, 2000\u20132004. Neuroepidemiology. 2008;29:250\u20134.","journal-title":"Neuroepidemiology"},{"key":"3683_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ophtha.2019.09.032","volume":"127","author":"JY Lee","year":"2020","unstructured":"Lee JY, Han J, Yang M, Oh SY. Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis. Ophthalmology. 2020;127:417\u201325.","journal-title":"Ophthalmology"},{"key":"3683_CR26","first-page":"1","volume":"0","author":"CA Rodr\u00edguez-Rodr\u00edguez","year":"2023","unstructured":"Rodr\u00edguez-Rodr\u00edguez CA, Cifuentes-Gonz\u00e1lez C, Mej\u00eda-Salgado G, Garz\u00f3n-Dangond JM, Verbel-Yaneth AV, Machado-Galindo S, et al. Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020. Ocul Immunol Inflamm. 2023;0:1\u20136.","journal-title":"Ocul Immunol Inflamm"},{"key":"3683_CR27","doi-asserted-by":"crossref","unstructured":"Haller P, Patzold U, Eckert G. Optic Neuritis in Hannover \u2014 An Epidemiologic and Serogenetic Study. In: Bauer HJ, Poser S, Ritter G, editors. Progress in Multiple Sclerosis Research. Berlin, Heidelberg: Springer; 1980. p. 546\u20138.","DOI":"10.1007\/978-3-642-67554-6_104"},{"key":"3683_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116554","volume":"408","author":"DD Choi","year":"2020","unstructured":"Choi DD, Park MS, Park KA. Incidence of optic neuritis in Korean children and adolescents: A Nationwide survey and National Registry Analysis. J Neurol Sci. 2020;408:116554.","journal-title":"J Neurol Sci"},{"key":"3683_CR29","doi-asserted-by":"crossref","unstructured":"Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011. Available from: http:\/\/jnnp.bmj.com\/content\/82\/10\/1132.","DOI":"10.1136\/jnnp.2011.240432"},{"key":"3683_CR30","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1177\/1352458519864681","volume":"26","author":"FB Briggs","year":"2020","unstructured":"Briggs FB, Hill E. Estimating the prevalence of multiple sclerosis using 56.6\u2009million electronic health records from the United States. Mult Scler J. 2020;26:1948\u201352.","journal-title":"Mult Scler J"},{"key":"3683_CR31","doi-asserted-by":"crossref","first-page":"E2029","DOI":"10.1073\/pnas.1520487113","volume":"113","author":"J Wang","year":"2016","unstructured":"Wang J, Syrett CM, Kramer MC, Basu A, Atchison ML, Anguera MC. Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X. Proc Natl Acad Sci USA. 2016;113:E2029\u201338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3683_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","volume":"80","author":"M Hittle","year":"2023","unstructured":"Hittle M, Culpepper WJ, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, et al. Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region. JAMA Neurol. 2023;80:693\u2013701.","journal-title":"JAMA Neurol"},{"key":"3683_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1212\/WNL.32.1.73","volume":"32","author":"Y Isayama","year":"1982","unstructured":"Isayama Y, Takahashi T, Shimoyoma T, Yamadori A. Acute optic neuritis and multiple sclerosis. Neurology. 1982;32:73\u201373.","journal-title":"Neurology"},{"key":"3683_CR34","doi-asserted-by":"publisher","first-page":"S865","DOI":"10.1007\/s100720070028","volume":"21","author":"A Ghezzi","year":"2000","unstructured":"Ghezzi A, Martinelli V, Rodegher M, Zaffaroni M, Comi G. The prognosis of idiopathic optic neuritis. Neurol Sci. 2000;21:S865\u20139.","journal-title":"Neurol Sci"},{"key":"3683_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/ijo.IJO_2235_21","volume":"70","author":"A Jossy","year":"2022","unstructured":"Jossy A, Jacob N, Sarkar S, Gokhale T, Kaliaperumal S, Deb AK. COVID-19-associated optic neuritis \u2013 A case series and review of literature. Indian J Ophthalmol. 2022;70:310.","journal-title":"Indian J Ophthalmol"},{"key":"3683_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/cen3.12682","volume":"13","author":"C Garc\u00eda-Estrada","year":"2022","unstructured":"Garc\u00eda-Estrada C, G\u00f3mez-Figueroa E, Alban L, Arias-C\u00e1rdenas A. Optic neuritis after COVID-19 vaccine application. Clin Exp Neuroimmunol. 2022;13:72\u20134.","journal-title":"Clin Exp Neuroimmunol"},{"key":"3683_CR37","doi-asserted-by":"crossref","unstructured":"Shukla P, Sharma N, Shaia JK, Cohen DA, Singh RP, Talcott KE. The Risk of Optic Neuritis following mRNA Coronavirus Disease 2019 Vaccination Compared to Coronavirus Disease 2019 Infection and Other Vaccinations. Ophthalmology. 2024;131:1076\u201382.","DOI":"10.1016\/j.ophtha.2024.02.024"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03683-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03683-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03683-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:26:02Z","timestamp":1747643162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03683-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3683"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03683-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RPS reports personal fees from Apellis, Iveric Bio, Eyepoint, Regenxbio, Genentech, Bausch and Lomb, Zeiss, Alcon, and Regeneron, and research grants from Jannsen. KET: Alimera (consultant),\u00a0Apellis (consultant),\u00a0Bausch and Lomb (consultant),\u00a0Eyepoint (consultant),\u00a0Genentech (consultant, speaker's bureau),\u00a0Iveric Bio (speaker's bureau),\u00a0Regeneron (research),\u00a0Regenxbio (research),\u00a0Zeiss (research). No conflicting relationship exists for any other author.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}